Clik here to view.
Committee pens letter to Mylan demanding EpiPen price info
Members of the U.S. House Committee on Oversight & Government Reform penned a letter to Mylan (NSDQ:MYL) demanding a more complete look at the pricing of its EpiPen epinephrine auto-injector. At a...
View ArticleClik here to view.
Color-changing wearable tracks sun exposure
Researchers have developed a wearable patch that warns users by changing colors when they’ve had too much sun exposure. Striking a balance between too much and too little sun exposure can be...
View ArticleClik here to view.
BD, Apax Partners close Vyaire respiratory JV deal, tap ex-Tornier chief...
Becton Dickinson & Co. (NYSE:BDX) said today it finalized the launch of a respiratory solutions joint venture with Apax Partners under the Vyaire Medical brand. The deal, which the companies...
View ArticleClik here to view.
Self-selecting peptides hold promise for drug delivery
Researchers have developed self-selecting polymers that form by adapting to their environment, according to a study published in Nature Nanotechnology yesterday. The peptides continually reorganize...
View ArticleClik here to view.
Report: EU regulators to rule on $25B Abbott-St. Jude Medical tie-up by Nov. 9
(Reuters) — Antitrust regulators in the European Union will decide by Nov. 9 whether to clear Abbott‘s (NYSE:ABT) $25-billion bid for St. Jude Medical (NYSE:STJ), aimed at helping it better compete...
View ArticleClik here to view.
Feds level wage discrimination charges at Analogic
Analogic (NSDQ:ALOG) is facing a suit from the U.S. Department of Labor alleging that it engaged in discriminatory pay practices against female assembly workers at its Peabody, Mass.-based...
View ArticleClik here to view.
Misonix CEO steps down | Personnel Moves October 4, 2016
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 4, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Samsung Biologics IPO could reach $2B, company value above $8B
Biotech drug contract manufacturer Samsung BioLogics could pull in as much as $2 billion through an initial public offering, according to regulatory filings posted this week. The figures would...
View ArticleClik here to view.
New chinese FDA list of medical devices exempt from clinical trial requirements
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: The China Food and Drug Administration (CFDA) has expanded the number of medical devices that do not require clinical trials for...
View ArticleClik here to view.
Researchers develop glucose-sensing contact lens
Researchers have developed a glucose-sensing contact lens as a noninvasive alternative to traditional glucose monitoring with blood tests. Glucose is a good target for optical sensing using...
View ArticleClik here to view.
QuiO raises $1m for smart injection device
QuiO said last week that it closed a $1.05 million seed round led by undisclosed investors to finish developing its smart injection device, prep for pilot studies and a 510(k) submission. The New...
View ArticleClik here to view.
Royal Philips debuts Volcano tech in Canada
Royal Philips (NYSE:PHG) said today that it debuted its Volcano catheter-based imaging and measurement systems for minimally invasive diagnostics and treatment of cardiovascular disease in Canada....
View ArticleClik here to view.
Stryker launches Lite Bio bone graft delivery system
Stryker (NYSE:SYK) said today it is launching the Lite Bio bone graft material delivery system device designed for spinal surgeries. The company said the device allows for the use of preferred graft...
View ArticleClik here to view.
Study is 1st to quantify ‘brain hacking’ tDCS fields
Researchers have successfully visualized the field of effect of transcranial direct current stimulation using a novel magnetic resonance imaging technique, according to a new study. Results from the...
View ArticleClik here to view.
How do you know when it’s time to hire a consultant?
By Chris Schorre, Emergo Group Has this happened to you lately? You spent countless hours online trying to research a specific topic, but still don’t have a solid understanding of how the process...
View ArticleClik here to view.
Nobel chemistry prize goes to molecular machinery
A group of European scientists won the 2016 Nobel Prize for chemistry for developing the “world’s smallest machines” that could be used for drug delivery. Jean-Pierre Sauvage, J. Fraser Stoddart and...
View ArticleClik here to view.
Vascular Solutions recalls Twin-Pass dual access caths
Vascular Solutions (NSDQ:VASC) said yesterday it initiated a nationwide recall of its Twin-Pass dual access catheters due to a potential for excess material in the catheter that could dislodge and pose...
View ArticleClik here to view.
Enable Injections lands $30m Series A for large-volume injector
Enable Injections Inc. said today that it closed a $30 million Series A round to bring its large-volume injector to market. The Cincinnati, Ohio-based company’s Enable Injector adheres to a patient’s...
View ArticleClik here to view.
How NxStage is changing the game: A conversation with founder & CEO Jeff Burbank
NxStage Medical (NSDQ:NXTM) was founded in 1999 on the premise that patients with chronic kidney disease would benefit from bringing hemodialysis out of the clinic and into their homes. Seventeen years...
View Article